Effectiveness and Safety of Acupuncture for Obesity and Over-weight People
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02108236|
Recruitment Status : Unknown
Verified March 2015 by Wang Ling Shu, Heilongjiang University of Chinese Medicine.
Recruitment status was: Recruiting
First Posted : April 9, 2014
Last Update Posted : March 26, 2015
|Condition or disease||Intervention/treatment||Phase|
|Obesity Overweight||Device: acupuncture||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||110 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Study Start Date :||May 2014|
|Estimated Primary Completion Date :||October 2015|
No Intervention: Blank control group
A control group of patients is put on a waiting list for no intervention and remaining unchanged lifestyle.
Active Comparator: intervention group
An intervention group of patients is put on a waiting list for acupuncture treatment.
Zhong-wan (RN12), Liang-men (ST21), Shui-fen (RN9) and Qi-hai (RN6) and bilateral acupuncture points Dai-mai (GB26), Tian-shu (ST25), Zu-sanli (ST36), Feng-long(ST40) and Liang-qiu(ST34) will be applied through the skin by acupuncture for 30 minutes every time. Electro-acupuncture apparatus will be connected to both Dai-mai, Zu-sanli and Feng-long, Zhong-wan and Qi-hai for 30 minutes with interrupted waves (2/100HZ).
- body mass index(BMI) [ Time Frame: 2 month after treatment ]
- waist-to-hip ratio (WHR) [ Time Frame: 2 month after treatment ]
- Blood sugar [ Time Frame: 2 month after treatment ]
- Total cholesterol [ Time Frame: 2 month after treatment ]
- Triglycerides [ Time Frame: 2 month after treatment ]
- High-density lipoprotein cholesterol [ Time Frame: 2 month after treatment ]
- Low-density lipoprotein cholesterol [ Time Frame: 2 month after treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02108236
|Contact: Xie Ning, PhD||086 email@example.com|
|The First Affiliated Hospital of Heilongjiang University of Chinese Medicine||Recruiting|
|Harbin, Heilongjiang, China, 150040|
|Principal Investigator:||Sun Zhongren||First Affiliated Hospital of Heilongjiang Chinese Medicine University|